Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ron Ellis"'
Autor:
Ron Ellis, Adam Weiss
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/a5856b73b68a4a60a781de5a2a10f882
Autor:
Ron Ellis, Adam Weiss
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/f194c6d32acf446a8130653414a6af05
Autor:
Sérgio Monteiro de Almeida, Jennifer Marquie-Beck, Archana Bhatt, Scott Letendre, Allen McCutchan, Ron Ellis
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 72, Iss 7, Pp 500-505 (2014)
Increased plasma lactate levels can indicate the presence of metabolic disorders in HIV infected individuals. Objective: To determine whether a portable analyzer is valid for measuring cerebrospinal fluid (CSF) and plasma lactate levels in HIV infect
Externí odkaz:
https://doaj.org/article/033fb54d73af4600a364786f78aebdcd
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 10, Iss 1, Pp 41-50
The pandemic of HIV/AIDS continues to grow daily. Incident cases among women, intravenous drug users and ethnic minorities comprise the fastest growing segment of the HIV-infected population, and the number of HIV-infected individuals over the age of
Externí odkaz:
https://doaj.org/article/b7d7b7ef7a524c578f6b71cc4037fed2
Autor:
Ron Ellis
Canadian legislatures regularly assign what are truly court functions to non-court, government tribunals. These executive branch'judicial'tribunals are surrogate courts and together comprise a little-known system of administrative justice that annual
Autor:
Ron Ellis, Adam Weiss
Publikováno v:
Human vaccinesimmunotherapeutics. 18(5)
Autor:
Ron Ellis, Adam Weiss
Publikováno v:
Human vaccinesimmunotherapeutics. 18(5)
Autor:
Natalie Carnahan, Yingjuan Lu, Aditya Shetty, Virginia Mohlere, Robert J. Amato, P. Ron Ellis, Philip S. Low
Publikováno v:
Journal of Immunotherapy. 37:237-244
Folate immune (EC90 vaccine with GPI-0100 adjuvant followed by EC17) is a novel folate-targeted hapten immunotherapy designed to exploit the overexpression of folate receptors on renal cell carcinoma (RCC) cells. In this open-label, phase I/II clinic
Autor:
Hari Krishna Santhapuram, Stephen J. Howard, Le-Cun Xu, Christopher P. Leamon, Elaine Westrick, P. Ron Ellis, Alicia Bloomfield, Iontcho Radoslavov Vlahov, Yingjuan Lu, Philip S. Low, Patrick J. Klein
Publikováno v:
The AAPS Journal. 11:628-638
Cancer vaccine/immunotherapy rarely involves systemic administration of an immunogenic compound to an actively immunized host. We have developed such a strategy that utilizes folate to deliver antigenic haptens [e.g., fluorescein (FITC) and dinitroph
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 36(4)
This is the first phase I, open-label study to assess the safety, pharmacokinetics, and antitumor activity of a novel immunotherapeutic regimen known as Folate Immune (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17, a folate-target